PMC:7321036 / 45844-46120
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T367 | 12-17 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T368 | 176-184 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T369 | 216-220 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T226 | 82-90 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T227 | 93-102 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T558 | 1-2 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
| T559 | 4-17 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
| T560 | 107-109 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T561 | 173-175 | http://purl.obolibrary.org/obo/CLO_0008192 | denotes | NP |
| T562 | 216-220 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T315 | 35-45 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T316 | 152-156 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T317 | 173-175 | Chemical | denotes | NP | http://purl.obolibrary.org/obo/CHEBI_50803|http://purl.obolibrary.org/obo/CHEBI_53793|http://purl.obolibrary.org/obo/CHEBI_73425 |
| T320 | 273-275 | Chemical | denotes | SD | http://purl.obolibrary.org/obo/CHEBI_74807 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 935 | 35-45 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 936 | 82-102 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
| 937 | 9-11 | CellLine | denotes | E6 | CVCL:4582 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T303 | 0-112 | Sentence | denotes | (B) Vero E6 cells pre-treated with remdesivir at the indicated doses, followed by SARS-CoV-2 infection for 48 h. |
| T304 | 113-251 | Sentence | denotes | Percent viral titer compared with mock drug treatment (anti-NP antibody; red line, dots, and text) and cell viability (black) is depicted. |
| T305 | 252-276 | Sentence | denotes | Error bars represent SD. |